We first confirmed our previous findings that NGN2, as a pioneer factor, could reprogram U251 human glioblastoma cells into neurons that are marked by expression of TUJ1 and MAP2 [3, 10]. This evidence concerns the gene NEUROG2 and glioblastoma.